Layoff details

Discussion in 'Novartis' started by Anonymous, Jul 10, 2014 at 11:43 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Finalized this week. To be announced around November 2014, and executed Jamuary 2015.

    MSBU - 70-80 percent cuts with a lot of white space
    Primary Care - 100 percent done
    Managed Markets - 80-90 percent cuts
    Oncology - untouched (why???)
    Derm - untouched for now
    IHC - 100 percent done (will be sold off to another company this year)

    Sorry to be bearer of bad news but it's best if you prepare now. By the way this includes ABLs not just reps.
     

  2. Anonymous

    Anonymous Guest

    When i see stuff like this i always ask why.....? What would be the reason to cut so many?
     
  3. Anonymous

    Anonymous Guest

    it's quite simple. the logic presented to everyone.

    we need to spend our hard-to-come buy profits into activities that actually care and cure patients.
     
  4. Anonymous

    Anonymous Guest

    "But my manager keeps telling me that our pipeline is best in class." Says the head in the sand rep.
     
  5. Anonymous

    Anonymous Guest

    Field ABL here, I did a rotation for 6 months at HQ. The reason is access. You all have very little impact, very low access even with lunch. You know it, I know it and HQ knows it!
     
  6. Anonymous

    Anonymous Guest

    We all knew it 10 years ago, why the change now?
     
  7. Anonymous

    Anonymous Guest

    Big Cuts Coming to Big Pharma

    On 06 May, 2014 Business Intelligence, Commercial Operations By : Greg Barlow No Comments

    In a recent white paper , the IMS Institute for Healthcare Economics projects that the largest 17 pharmaceutical companies will need to cut over $35B through 2017 to maintain their current levels of research and development yet also maintain their operating margins. Why is that? With many companies facing patent cliffs of their blockbuster drugs (and the rise of generics) coupled with the increasing influence of payers, pharmaceutical companies are having a harder time generating top line revenue.

    In IMS’ survey, they found that over 45% of executives planned to cut costs more than 10% over the next three years. The sources of cost cutting will vary, but with sales, marketing and administration accounting for over 30% of sales costs, these groups would seem the most likely targets. Within commercial operations, for example, 40% of those surveyed expect cuts to be more than 10% and 20% expect the cuts to be more than 15% over the next three years.

    http://verix.com/big-cuts-coming-big-pharma/
     
  8. Anonymous

    Anonymous Guest

    Typical dm. Notice how he use"you all". Like dm s are not part of the machine. Of course charging sky high
    prices and treating our customers and employee s like sh....t for 7 years has nothing to do with poor access.
     
  9. Anonymous

    Anonymous Guest

    Ten years ago access was much much better and blockbusters like Lipitor, Viagra, Advair, Diovan etc were in full swing. It's 2014. Name a single blockbuster that launched recently. Just one! Access in Oncology and MS in non existent but they still kinda have to talk to you due to difficulty of starting drug. Primary Care? Forget about it. Like a limp dick. Go find a job selling something else
     
  10. Anonymous

    Anonymous Guest

    Abl? Area business leader? leader of what? Go approve my expense report monkey and schedule a conference call do so you have something to do.
     
  11. Anonymous

    Anonymous Guest

    Believe it or not both you and I are on the same team and we are BOTH at risk of getting laid off. Quit playing the me against you crap would you? We both have to find new careers and soon. By the way I did not choose this title. It was Novartis. I don't care about titles, just money and security which there isn't much of in pharma anymore.

    The only difference between you and us are the following:
    #1 We make more in base/bonus than you (not by much)
    #2 We interact with HQ personnel a little more than you
    #3 We have to "coach" whereas you have to sell

    The bottom line is that WE have ZERO impact on both you and our customers. YOU have ZERO IMPACT on your customers. WE BOTH are at risk!
     
  12. Anonymous

    Anonymous Guest

    Well thats better. I take it back. Nice to see some concern from you. Show concern for your team and you will really get some respect.
     
  13. Anonymous

    Anonymous Guest

    Getting back to layoff talk, i thought ihc was getting ready for lcz
     
  14. Anonymous

    Anonymous Guest

    Glad you feel that way, because as they get rid of the 'worthless' sales reps, there is no need for the layers of management and specialty positions sitting on their shoulders.

    So keep in mind while you make cutting remarks ( true or not) you butt is one step closer to the unemployment line too!

    As they peel back the layers of the onion, they will find many layers of useless positions, so don't puff your chest out too far.

    We all know the truth.
     
  15. Anonymous

    Anonymous Guest

    Ah the true abl mind shows himself minutes later, enjoy your "office day" and use your mba to check sync times!
     
  16. Anonymous

    Anonymous Guest

    Is this a real post and not some made up Cafe pharma bullshit? Please, original poster do you have anymore details? Are you in HQ? In previous layoffs there was actually some good info on here. Just want to make sure. I know there has been a rumor for the while about the roll up of primary care, but I'm not hearing any of the other rumors, such as MS, and etc. in the field...
     
  17. Anonymous

    Anonymous Guest

    Not OP but I do work in HQ... Hate to say it but OP was spot on. I know because I've sat on several of those meetings. My advice to you - especially those in primary care is to look for a new job now. Please do not wait until the end. It's easier to find a job while you have one. Novartis does not want any part of Primary Care. None. Do what's best for your family. Unfortunately most of you won't believe me or OP. And you won't do a thing. My hope is that at least a few of you reading this will cut your losses and look for a new job. MS will have 80 percent cuts and Onc will survive only due to the new product launches. Serelaxin is done. Talks of this being sold off.
     
  18. Anonymous

    Anonymous Guest

    Of course Serelaxin is done! If you really think about it why keep even a skeleton PC division when they can get more money for selling off anything they can get for it. Acute data stinks and any decent promise of data with chronic is what they will use to sell the product to get the most that they can. Novartis is specialty pharma going forward. PC is totally done. Trust the OP and take care of yourself now and find a new job whir you have a job. Companies always want a good catch and you're not as "hot of a prospect" when you're unemployed. Take care of yourself first.
     
  19. Anonymous

    Anonymous Guest

    The smart reps are just waiting for the upcoming bonus to hit and then they are long gone.
     
  20. Anonymous

    Anonymous Guest

    Everyone in pc is getting out. My district is down 30%. The only one s that are staying are kams and dms.....im sorry, area business leaders.